As PMA/ionomycin activated the PKC/NFκB pathway and abrogated venetoclax cytotoxicity, we reasoned that stimuli that converge on the NFκB pathway are important for survival and resistance of CLL cells to venetoclax. The gene discussed is PRRT2; the disease is B-cell chronic lymphocytic leukemia.